title: What have we learnt from the rosiglitazone saga?
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
authors.forename: Nilay D
authors.initials: ND
authors.lastname: Shah
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone